E1308: A Phase II Trial of Induction Chemotherapy Followed by Cetuximab with Low Dose vs. Standard Dose IMRT in Patients with HPV-Associated Resectable.
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
